NYSE$ATR

AptarGroup Inc. · Q4 2019 earnings

Q4 2019 earnings · · Investor relations

Briefing

AptarGroup's Q4 2019 financial performance was reported, with sales decreasing due to currency exchange rates and core sales declining due to lower resin costs, while strategic steps were highlighted to strengthen the beauty business.

AptarGroup reported a decrease in sales for Q4 2019, with reported sales at $671 million, a 2% decrease compared to the previous year, impacted by currency exchange rates and lower resin costs. The Pharma segment experienced core sales growth, which was offset by decreases in other segments. Reported earnings per share were $0.73, while adjusted earnings per share were $0.80.

  • Reported sales decreased by 2% due to currency exchange rates.
  • Core sales declined by 1% due to lower resin costs.
  • Pharma segment's core sales growth was offset by decreases in other segments.
  • Adjusted earnings per share decreased to $0.80 from $0.92 in the prior year.

Headline financials

Total Revenue

$671M

Previous: $685M-2.0%
EPS (adj)

$0.80

Previous: $0.92-13.0%
Total Core Sales Growth

-1.0%

No prior period
Pharma Core Sales Growth

4.0%

No prior period
Beauty Core Sales Growth

-5.0%

No prior period
Closures Core Sales Growth

-1.0%

No prior period
Capital Expenditures

$55.4M

Previous: $65.9M-15.9%
Free Cash Flow

$78.6M

Previous: $38.1M+106.3%
Net Income

$48.5M

Previous: $40.7M+19.3%
Operating Income

$74.5M

Previous: $56.3M+32.4%
Gross Profit

$236M

Previous: $228M+3.6%
Cash & Equivalents

$242M

Previous: $262M-7.6%
Total Assets

$3.56B

Previous: $3.38B+5.5%
Stock-Based Comp

$5.82M

Previous: $4.73M+23.0%

Revenue & EPS history

AptarGroup · Revenue · Quarterly

$671M

Q4 2019-2%vs Q4 2018
Beat estimate in 15 of 16 quarters(94%)
ActualEstimate

Revenue by segment

AptarGroup · $671M total across 3 segments · Q4 2019

  • Beauty
    $315M-6.8%
  • Pharma
    $267M+4.4%
  • Closures
    $89.4M-2.1%

Forward guidance

Aptar expects earnings per share for the first quarter of 2020, excluding any restructuring costs and acquisition-related expenses, to be in the range of $0.85 to $0.93 and this guidance is based on an effective tax rate range of 28% to 30%.

Tailwinds

  • Optimistic about the long-term opportunities for growth
  • Excited about recent strategic acquisitions and investments.

Headwinds

  • Beauty + Home customers continuing to focus on inventory reductions
  • Current macroeconomic uncertainties including the negative impact of the coronavirus outbreak
  • Travel retail industry is particularly exposed
  • Pharma segment is facing difficult comparisons compared to the prior year’s exceptional growth
  • Food + Beverage segment’s Asian business may also be negatively affected by the coronavirus impact.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2019

Historical avgQ4 2019

+0.3%

Avg return

Earnings day

-0.1%

Avg return

5 days after

+1.2%

Avg return

30 days after

63%

43 / 68 earnings

Positive

+9.2%

Q4 2017

Best reaction

-9.0%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-3.3%-0.8%-6.4%
Q4 2025+8.3%+12.9%+6.5%
Q3 2025-9.0%-7.1%+0.3%
Q1 2025+2.3%+2.1%+6.8%
Q4 2024-8.5%-9.4%-2.3%
Q3 2024+0.8%+0.6%+2.3%
Q2 2024+1.7%+1.1%+4.4%
Q1 2024+2.4%+3.1%+5.8%
Q4 2023+5.4%+3.1%+8.6%
Q3 2023+0.1%-0.9%+4.2%
Q2 2023+3.2%+2.1%+6.3%
Q1 2023+2.4%+4.1%-1.4%
Q4 2022+5.7%+4.2%+0.3%
Q3 2022+2.1%-1.9%+6.9%
Q2 2022+1.6%+0.5%-1.5%
Q1 2022+3.4%+2.5%-2.0%
Q4 2021+3.3%+3.8%+2.7%
Q3 2021-3.6%+1.7%+1.0%
Q2 2021-6.3%-6.6%-2.3%
Q1 2021-0.2%+2.6%-2.5%
Q4 2020-7.7%-10.4%-2.7%
Q3 2020+1.6%+6.4%+13.3%
Q2 2020-3.0%-0.2%-0.6%
Q1 2020-3.6%-4.1%+1.2%
Q4 2019-2.6%-7.0%-19.6%
Q3 2019-7.1%-8.9%-6.0%
Q2 2019-5.0%-5.4%-1.3%
Q1 2019+1.3%+2.3%+2.0%
Q4 2018+1.5%+0.0%+2.2%
Q3 2018+1.8%+2.1%+2.0%
Q2 2018+8.6%+8.1%+9.6%
Q1 2018+0.3%+0.4%+1.0%
Q4 2017+9.2%+11.8%+9.6%
Q3 2017-0.6%-1.6%-2.5%
Q2 2017-6.5%-6.3%-6.4%
Q1 2017+1.2%+1.1%+6.3%
Q4 2016+1.7%+0.4%+4.4%
Q3 2016-4.3%-7.4%-0.3%
Q2 2016-1.9%-3.9%-1.6%
Q1 2016-3.1%
Q4 2015-2.8%
Q3 2015+2.4%
Q2 2015+8.3%
Q1 2015+2.4%
Q4 2014+1.8%
Q3 2014+2.0%
Q2 2014-3.5%
Q1 2014-0.1%
Q4 2013+1.9%
Q3 2013+0.2%
Q2 2013-2.1%
Q1 2013-2.0%
Q4 2012-0.8%
Q3 2012-3.5%
Q2 2012+2.6%
Q1 2012+0.9%
Q4 2011+0.1%
Q3 2011+5.8%
Q2 2011-5.0%
Q1 2010+2.2%
Q1 2011+2.3%
Q4 2008+1.5%
Q4 2010+1.5%
Q3 2010+2.9%
Q3 2009+2.9%
Q4 2009+0.5%
Q2 2009+0.5%
Q2 2010+0.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro